Skip to main content

Company News

December 19, 2024

Celebrating innovation with Professor Ding: A pioneer in sustainable endotoxin testing

A world-renowned pioneer in the field of molecular biotechnology and currently Emeritus Professor at the Department of Biological Sciences, National University of Singapore (NUS), Professor Jeak Ling Ding’s research focuses on innate immunity in host-pathogen interaction, antimicrobial defense and anticancer immunomodulation. Her work has resulted in around 300 scientific publications and patents, along with a host of awards and honors, including most recently her induction into the Singapore Women’s Hall of Fame. We spoke with Professor Ding to learn more about her career defining breakthrough to genetically engineer recombinant Factor C, and the importance of creating a sustainable and ethical alternative to replace traditional methods of endotoxin testing.
Discover More

  • November 22, 2024

    bioMérieux and St James’s Hospital in Ireland announce the world-first Data & IT Centre of Reference partnership

    On November 14th, 2024, bioMérieux officially launched its first Data & IT Centre of Reference partnership with St James's Hospital in Dublin, Ireland. This landmark collaboration has been celebrated with an event held at the Davis Coakley Lecture Theatre, St James's Hospital.
    Read more

  • November 21, 2024

    A 100% digital campaign to raise awareness about antimicrobial resistance

    Globally, it was estimated that approximately 4.95 million people died from Antimicrobial Resistance-related causes in 20191. And yet, one in three adults doesn’t understand what this term means2. Faced with this alarming situation, an awareness-raising campaign encourages the general public to change their behaviour with regard to the use of antibiotics. Indeed, each person, at their own level, has a role to play to preserve their effectiveness.
    Read more

  • November 13, 2024

    bioMérieux signed an Agreement to acquire Neoprospecta

    bioMérieux, a world leader in the field of in vitro diagnostics, signed in November 2024 a Sale and Purchase Agreement (SPA) to acquire Neoprospecta. This company, based in Florianopolis, Brazil, develops and markets innovative user-friendly data and genomics solutions for augmenting quality assurance programs and improve microbiological risk prevention in food and pharma industries.
    Read more

  • October 10, 2024

    Advancing the Global AMR Agenda: A Call for Multi-Sector Collaboration

    On the sidelines of the 2024 United Nations High-Level Meeting on Antimicrobial Resistance (AMR), a multisectoral event titled “Advancing Together: Securing the Global AMR Agenda by Harnessing the Collective Strength of Multi-Sector Partnerships” took place on September 24 in New York. bioMérieux, in partnership with The Wellcome Trust, The American Society of Microbiology, Malawi, and the French Republic, organized the event to focus on fostering a collaborative ecosystem that establishes sustainable solutions across the entire AMR landscape. From diagnosis and treatment to surveillance and action plans, this initiative spanned human health, animals, and the environment.
    Read more

Follow us on Socials for more news!